Company: JUNS
Filing Date: 2025-11-26
Form Type: S-1
Source: 0001493152-25-025204
Chunk: 295

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-26
Form: S-1
Chunk 295
---
 is necessary to attract and retain qualified directors and officers.

Insofar as indemnification
for liabilities arising under the Securities Act may be permitted to our directors, officers, and controlling persons pursuant to the
foregoing provisions, or otherwise, we have been advised that, in the opinion of the SEC, such indemnification is against public policy
as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities
(other than the payment of expenses incurred or paid by a director, officer or controlling person in a successful defense of any action,
suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, we
will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to the court of appropriate jurisdiction
the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the
final adjudication of such issue.

| Item 15. | Recent Sales of Unregistered Securities |

The Company has not sold any securities within
the past three years which were not registered under the Securities Act except as set forth below. The registrant believes that, unless
otherwise noted, all of the transactions described in Item 15 were exempt from registration under the Securities Act pursuant to Section
4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated thereunder.

| June 1, 2021 Option Grant to Alexander Rosén, our Chief Administrative Officer              |     | July 14, 2022 |     | Amendment |     | Incentive Stock Option; Common Stock     |     | 168,750 |     | $ | 1.33 |
| June 1, 2021 Option Grant to Dana Eschenburg Perez, our former Chief Financial Officer      |     | July 14, 2022 |     | Amendment |     | Incentive Stock Option; Common Stock     |     | 193,125 |     | $ | 1.33 |
| August 1, 2021 Option Grant to Dana Eschenburg Perez, our former Chief Financial Officer    |     | July 14, 2022 |     | Amendment |     | Incentive Stock Option; Common Stock     |     | 193,125 |     | $ | 1.33 |
| June 22, 2021 Option Grant to W. Dalton Dietrich III,